Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial

被引：0
|
作者：
Vivian, Lee [1 ]
Omeed, Alipour [2 ]
Tapas, Tejura [1 ]
Melissa, Wilson [1 ]
Zoe, Memel [3 ]
Kyle, Cologne [1 ]
Caroline, Hwang [4 ]
Ling, Shao [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Hoag Hosp, Newport Beach, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
10.14309/01.ajg.0000722852.81814.04
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P014
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [31] PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY
    Lee, Jimin
    Lester, Robert
    Lowe, Ezra
    Franklin, Howard
    Israel, Robert
    Laitman, Adam
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S75 - S75
  • [32] PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY
    Lee, Jimin
    Lester, Robert
    Lowe, Ezra
    Franklin, Howard
    Israel, Robert
    Laitman, Adam
    GASTROENTEROLOGY, 2023, 164 (04) : S96 - S96
  • [33] Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects
    Anderson, Kacey
    Xin, Yan
    Zheng, Hao
    Yun, Chohee
    Kwan, Ellen
    Qin, Ann
    Namour, Florence
    Kearne, Brian R.
    Mathias, Anita
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (01): : 32 - 40
  • [34] Pharmacokinetic/Pharmacodynamic Analysis of Amiselimod, a Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects: Results From a Phase 1 Study
    Jimin, Lee
    Robert, Lester
    Terry, O'Reilly
    Ezra, Lowe
    Neal, Slatkin
    Howard, Franklin
    Robert, Israel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S7 - S7
  • [35] Sucralose decreases insulin sensitivity in healthy subjects: a randomized controlled trial
    Romo-Romo, Alonso
    Aguilar-Salinas, Carlos A.
    Brito-Cordova, Griselda X.
    Gomez-Diaz, Rita A.
    Almeda-Valdes, Paloma
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (03): : 485 - 491
  • [36] Impact of Phase 1 study design on estimation of QT interval prolongation risk using exposure-response analysis
    Tsamandouras, Nikolaos
    Duvvuri, Sridhar
    Riley, Steve
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (06) : 605 - 616
  • [37] Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
    Ruwaard, J.
    Ami, M. J. L'
    Kneepkens, E. L.
    Krieckaert, C. L. M.
    Nurmohamed, M. T.
    Hooijberg, F.
    van Kuijk, A. W. R.
    van Denderen, J. C.
    Burgemeister, L.
    Rispens, T.
    Boers, M.
    Wolbink, G. J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (02) : 129 - 136
  • [38] Absence of QTc prolongation with semaglutide: a thorough QT/QTc study in healthy subjects
    Demmel, V.
    Sandberg-Schaal, A.
    Jacobsen, J. B.
    Golor, G.
    Flint, A.
    Pettersson, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1128 - 1129
  • [39] Effect of acute hypoxia on QT rate dependence and corrected QT interval in healthy subjects
    Roche, F
    Reynaud, C
    Pichot, V
    Duverney, D
    Costes, F
    Garet, M
    Gaspoz, JM
    Barthélémy, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (07): : 916 - 919
  • [40] Effect of Vicriviroc on the QT/Corrected QT Interval and Central Nervous System in Healthy Subjects
    O'Mara, Edward
    Kasserra, Claudia
    Huddlestone, John Robert
    Wan, Yuntao
    Soni, Peter
    Caceres, Maria
    Medlock, Matthew
    Morrison, Royce
    Devinsky, Orrin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2448 - 2454
12345